The possibility of sleeper cells inflicting terror domestically has “never been higher” following attacks on Iran, according to an agency chief. However, there ...

Manufacturing difficulties are holding back the commercial development of heart disease cell therapies, according to researchers who say “cell free” treatment could be an easy-to-make alternative. A ...

Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds ...